1. Home
  2. VLY vs KYMR Comparison

VLY vs KYMR Comparison

Compare VLY & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Valley National Bancorp

VLY

Valley National Bancorp

HOLD

Current Price

$11.56

Market Cap

5.2B

Sector

Finance

ML Signal

HOLD

Logo Kymera Therapeutics Inc.

KYMR

Kymera Therapeutics Inc.

HOLD

Current Price

$66.59

Market Cap

4.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VLY
KYMR
Founded
1927
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.2B
4.7B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
VLY
KYMR
Price
$11.56
$66.59
Analyst Decision
Buy
Strong Buy
Analyst Count
14
19
Target Price
$12.93
$69.58
AVG Volume (30 Days)
7.3M
698.8K
Earning Date
01-22-2026
11-04-2025
Dividend Yield
3.81%
N/A
EPS Growth
40.78
N/A
EPS
0.88
N/A
Revenue
$1,704,193,000.00
$43,735,000.00
Revenue This Year
$33.72
$20.81
Revenue Next Year
$10.10
N/A
P/E Ratio
$13.13
N/A
Revenue Growth
8.06
N/A
52 Week Low
$7.48
$19.45
52 Week High
$11.65
$68.80

Technical Indicators

Market Signals
Indicator
VLY
KYMR
Relative Strength Index (RSI) 64.52 60.17
Support Level $11.21 $63.69
Resistance Level $11.60 $68.78
Average True Range (ATR) 0.30 2.85
MACD 0.06 -0.20
Stochastic Oscillator 91.22 63.67

Price Performance

Historical Comparison
VLY
KYMR

About VLY Valley National Bancorp

Valley National Bancorp is a bank holding company that offers a full suite of national and regional banking solutions through various commercial, private banking, retail, insurance, and wealth management financial services products. It provides personalized service and customized solutions to assist its customers with their financial service needs. The group also offers niche financial services, including loan and deposit products for homeowners associations, cannabis-related business banking, and venture banking, which offers nationally. It manages its business operations under operating segments consisting of Consumer Banking; Commercial Banking; and Treasury and Corporate Other. The group generates the majority of its revenue from the Commercial Banking Segment.

About KYMR Kymera Therapeutics Inc.

Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.

Share on Social Networks: